BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 23300450)

  • 21. Targeting of EBNA1 for rapid intracellular degradation overrides the inhibitory effects of the Gly-Ala repeat domain and restores CD8+ T cell recognition.
    Tellam J; Sherritt M; Thomson S; Tellam R; Moss DJ; Burrows SR; Wiertz E; Khanna R
    J Biol Chem; 2001 Sep; 276(36):33353-60. PubMed ID: 11435434
    [TBL] [Abstract][Full Text] [Related]  

  • 22. mRNA translation regulation by the Gly-Ala repeat of Epstein-Barr virus nuclear antigen 1.
    Apcher S; Komarova A; Daskalogianni C; Yin Y; Malbert-Colas L; Fåhraeus R
    J Virol; 2009 Feb; 83(3):1289-98. PubMed ID: 19019958
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reduction in RNA levels rather than retardation of translation is responsible for the inhibition of major histocompatibility complex class I antigen presentation by the glutamic acid-rich repeat of herpesvirus saimiri open reading frame 73.
    Gao J; Coulson JM; Whitehouse A; Blake N
    J Virol; 2009 Jan; 83(1):273-82. PubMed ID: 18945762
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human CD8+ T cell responses to EBV EBNA1: HLA class I presentation of the (Gly-Ala)-containing protein requires exogenous processing.
    Blake N; Lee S; Redchenko I; Thomas W; Steven N; Leese A; Steigerwald-Mullen P; Kurilla MG; Frappier L; Rickinson A
    Immunity; 1997 Dec; 7(6):791-802. PubMed ID: 9430224
    [TBL] [Abstract][Full Text] [Related]  

  • 25. G-quadruplexes regulate Epstein-Barr virus-encoded nuclear antigen 1 mRNA translation.
    Murat P; Zhong J; Lekieffre L; Cowieson NP; Clancy JL; Preiss T; Balasubramanian S; Khanna R; Tellam J
    Nat Chem Biol; 2014 May; 10(5):358-64. PubMed ID: 24633353
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen 1 mimics Epstein-Barr virus EBNA1 immune evasion through central repeat domain effects on protein processing.
    Kwun HJ; da Silva SR; Shah IM; Blake N; Moore PS; Chang Y
    J Virol; 2007 Aug; 81(15):8225-35. PubMed ID: 17522213
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Full-length EBNA1 mRNA-transduced dendritic cells stimulate cytotoxic T lymphocytes recognizing a novel HLA-Cw*0303- and -Cw*0304-restricted epitope on EBNA1-expressing cells.
    Ito Y; Demachi-Okamura A; Ohta R; Akatsuka Y; Nishida K; Tsujimura K; Morishima Y; Takahashi T; Kuzushima K
    J Gen Virol; 2007 Mar; 88(Pt 3):770-780. PubMed ID: 17325349
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulation of protein translation through mRNA structure influences MHC class I loading and T cell recognition.
    Tellam J; Smith C; Rist M; Webb N; Cooper L; Vuocolo T; Connolly G; Tscharke DC; Devoy MP; Khanna R
    Proc Natl Acad Sci U S A; 2008 Jul; 105(27):9319-24. PubMed ID: 18591662
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The nascent polypeptide-associated complex (NAC) controls translation initiation in cis by recruiting nucleolin to the encoding mRNA.
    Zheng AJL; Thermou A; Daskalogianni C; Malbert-Colas L; Karakostis K; Le Sénéchal R; Trang Dinh V; Tovar Fernandez MC; Apcher S; Chen S; Blondel M; Fahraeus R
    Nucleic Acids Res; 2022 Sep; 50(17):10110-10122. PubMed ID: 36107769
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of ubiquitin/proteasome-dependent protein degradation by the Gly-Ala repeat domain of the Epstein-Barr virus nuclear antigen 1.
    Levitskaya J; Sharipo A; Leonchiks A; Ciechanover A; Masucci MG
    Proc Natl Acad Sci U S A; 1997 Nov; 94(23):12616-21. PubMed ID: 9356498
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of a naturally processed HLA-DR-restricted T-helper epitope in Epstein-Barr virus nuclear antigen type 1.
    Krüger S; Schroers R; Rooney CM; Gahn B; Chen SY
    J Immunother; 2003; 26(3):212-21. PubMed ID: 12806275
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of an human leucocyte antigen A2-restricted Epstein-Barr virus nuclear antigen-1-derived cytotoxic T-lymphocyte epitope.
    Marescotti D; Destro F; Baldisserotto A; Marastoni M; Coppotelli G; Masucci M; Gavioli R
    Immunology; 2010 Mar; 129(3):386-95. PubMed ID: 19922423
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of MEF2B, EBF1, and IL6R as Direct Gene Targets of Epstein-Barr Virus (EBV) Nuclear Antigen 1 Critical for EBV-Infected B-Lymphocyte Survival.
    Tempera I; De Leo A; Kossenkov AV; Cesaroni M; Song H; Dawany N; Showe L; Lu F; Wikramasinghe P; Lieberman PM
    J Virol; 2016 Jan; 90(1):345-55. PubMed ID: 26468528
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Proteasome inhibitors induce the presentation of an Epstein-Barr virus nuclear antigen 1-derived cytotoxic T lymphocyte epitope in Burkitt's lymphoma cells.
    Destro F; Sforza F; Sicurella M; Marescotti D; Gallerani E; Baldisserotto A; Marastoni M; Gavioli R
    Immunology; 2011 May; 133(1):105-14. PubMed ID: 21342184
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Avoiding proteasomal processing: the case of EBNA1.
    Dantuma NP; Sharipo A; Masucci MG
    Curr Top Microbiol Immunol; 2002; 269():23-36. PubMed ID: 12224511
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epstein-Barr virus evasion of CD8(+) and CD4(+) T cell immunity via concerted actions of multiple gene products.
    Ressing ME; Horst D; Griffin BD; Tellam J; Zuo J; Khanna R; Rowe M; Wiertz EJ
    Semin Cancer Biol; 2008 Dec; 18(6):397-408. PubMed ID: 18977445
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structural Basis for Cooperative Binding of EBNA1 to the Epstein-Barr Virus Dyad Symmetry Minimal Origin of Replication.
    Malecka KA; Dheekollu J; Deakyne JS; Wiedmer A; Ramirez UD; Lieberman PM; Messick TE
    J Virol; 2019 Oct; 93(20):. PubMed ID: 31142669
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A yeast model for the mechanism of the Epstein-Barr virus immune evasion identifies a new therapeutic target to interfere with the virus stealthiness.
    Lista MJ; Martins RP; Angrand G; Quillévéré A; Daskalogianni C; Voisset C; Teulade-Fichou MP; Fåhraeus R; Blondel M
    Microb Cell; 2017 Aug; 4(9):305-307. PubMed ID: 28913345
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alterations in the structure of the EBV nuclear antigen, EBNA1, in epithelial cell tumours.
    Snudden DK; Smith PR; Lai D; Ng MH; Griffin BE
    Oncogene; 1995 Apr; 10(8):1545-52. PubMed ID: 7731709
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of the EBNA1 proteins of Epstein-Barr virus and herpesvirus papio in sequence and function.
    Yates JL; Camiolo SM; Ali S; Ying A
    Virology; 1996 Aug; 222(1):1-13. PubMed ID: 8806482
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.